Anika Therapeutics Inc. (ANIK) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Anika Therapeutics Inc. (ANIK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

15.59

-0.33 (-2.07%)

At close: Jan 14, 2025, 3:59 PM

15.58

-0.06%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	12.9
Market Cap	228.32M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-6.64
PE Ratio (ttm)	-2.35
Forward PE	n/a
Analyst	Buy

Ask	16.54
Volume	37,396
Avg. Volume (20D)	101,691
Open	15.85
Previous Close	15.92
Day's Range	15.49 - 15.89
52-Week Range	15.40 - 29.12
Beta	undefined

About ANIK

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date May 3, 1993

Employees 357

Stock Exchange NASDAQ

Ticker Symbol ANIK

Website https://www.anikatherapeutics.com

Analyst Forecast

According to 2 analyst ratings, the average rating for ANIK stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 57.15% from the latest price.

Buy 50.00%

Hold 50.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Anika Therapeutics Inc. is scheduled to release its earnings on Mar 12, 2025, during market hours.
Analysts project revenue of $29.00M, reflecting a -32.51% YoY shrinking and earnings per share of 0.09, making a 80.00% increase YoY.

Why Price Moved

2 months ago · Source

-30.67%

Anika Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

News

2 months ago · zacks.com

New Strong Sell Stocks for November 11th

AMRK, ANIK and ALG have been added to the Zacks Rank #5 (Strong Sell) List on November 11, 2024.

2 months ago · seekingalpha.com

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Matt Hall - Director, Corporate Development and IR Cheryl Blanchard - Presiden...

2 months ago · zacks.com

Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates

Anika Therapeutics (ANIK) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of $0.30. This compares to loss of $0.45 per share a year ago.